{"id":2537,"date":"2017-12-15T18:32:15","date_gmt":"2017-12-15T15:32:15","guid":{"rendered":"http:\/\/ufuture.com\/?p=2537"},"modified":"2017-12-15T18:33:53","modified_gmt":"2017-12-15T15:33:53","slug":"biofarma-open-blood-plasma-fractionator-plant-july-2018","status":"publish","type":"post","link":"https:\/\/ufuture.com\/en\/biofarma-open-blood-plasma-fractionator-plant-july-2018\/","title":{"rendered":"Biofarma could open blood plasma fractionator plant in July 2018"},"content":{"rendered":"<p>KYIV. Dec 15 (Interfax-Ukraine) \u2013 Biofarma pharmaceutical company seeks to launch a blood plasma fractionator plant in July 2018, Biofarma President Kostiantyn Yefymenko has written on his Facebook page.<\/p>\n<blockquote><p>&#8220;In December, we will receive separators from the German company GEA Westfalia, in February &#8211; the bioreactor of the Italian company Olsen, chromatographic complexes and ultrafiltration units from the world&#8217;s leading companies such as General Electric, the Marchesini bottling line and in July we are opening a modern fractionator plant,&#8221; <cite>he said <\/cite><\/p><\/blockquote>\n<p>The projected capacity of the fractionator, in the construction of which $ 35 million was invested, will amount to 500 tonnes of blood plasma.<\/p>\n<blockquote><p>&#8220;We have a clear goal and plan to become the world&#8217;s leader in deliveries to the market. We have the ambition of being among the seven largest global producers of blood plasma,&#8221; <cite>Yefymenko said <\/cite><\/p><\/blockquote>\n<p>Biofarma is among the ten largest Ukrainian manufacturers of medical products. It produces more than 20 immunobiological drugs from donor blood.<\/p>\n<p><a href=\"http:\/\/sub.interfax.kiev.ua\/eng\/tape\/294442274\/4302230\/\" target=\"_blank\" rel=\"noopener\">Interfax<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>KYIV. Dec 15 (Interfax-Ukraine) \u2013 Biofarma pharmaceutical company seeks to launch a blood plasma fractionator plant in July 2018, Biofarma&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts\/2537"}],"collection":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/comments?post=2537"}],"version-history":[{"count":3,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts\/2537\/revisions"}],"predecessor-version":[{"id":2541,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/posts\/2537\/revisions\/2541"}],"wp:attachment":[{"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/media?parent=2537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/categories?post=2537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ufuture.com\/en\/wp-json\/wp\/v2\/tags?post=2537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}